Good day all,
Trying to see if anyone is already using ADSTILADRIN® (nadofaragene firadenovec-vncg) in any of their outpatient sites. This is a fairly new drug indicated for adult patients with high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).
In some respects, it seems this may be a good alternative to chemotherapeutic, which are hard to compound in an outpatient setting. However, I have never dealt with gene therapy and I am having some difficulty in finding anyone with real-world experience.
Appreciate this community!
------------------------------
Scott Kaye , PhD RN-BC CEN CPEN CCRN CJCP NPD-BC AMB-BC
Clinical Director
Bayside NY
(917)365-5839
scottpaulkaye@hotmail.com------------------------------